Welcome to our dedicated page for Corvex SEC filings (Ticker: MOVE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Corvex, Inc. filings document the company's public-company transition, material-event reporting, securities registration activity, and capital structure. Recent 8-K reports cover material agreements, shareholder voting matters, governance matters, operating and financial results, and Nasdaq listing-compliance disclosures for the MOVE common stock.
Registration statements filed under the former Movano Inc. name describe offered securities, issuer status as a smaller reporting company and emerging growth company, and delayed or continuous offering mechanics. The filing record also documents the completed merger-related change to Corvex, Inc. and related capitalization and governance disclosures.
Seth Demsey, Co-Chief Executive Officer and director of Corvex, Inc., reports beneficial ownership of 5,540,329 shares of the company’s common stock, representing 20.0% of the 27,635,745 shares outstanding as of July 7, 2026. These shares include 5,508,920 held directly and 31,409 held through Ainsworth Holdings, LLC, over which he has sole voting and dispositive power. He also holds additional unvested restricted stock units and unexercisable stock options that are excluded from this 20.0% figure. Demsey received these shares primarily as consideration for Corvex, Inc.’s acquisition of Corvex Legacy Holdings, Inc. and for his executive and board service, giving him significant influence over the company’s governance and strategic direction.
Corvex, Inc. director and Co-CEO Seth Demsey reported automatic conversions of Series C preferred stock into common stock. On July 7, 2026, 5,484.3883 shares of Series C Non-Voting Convertible Preferred Stock converted into 5,484,388 shares of common stock at a 1-to-1,000 ratio, increasing his direct common stock holdings to 8,563,155 shares. A further 31.2700 preferred shares held through Ainsworth Holdings, LLC converted into 31,270 common shares, bringing Ainsworth’s indirectly held common stock to 31,409 shares. After these conversions, no Series C preferred stock remains outstanding for Demsey in this filing.
Corvex, Inc. director and Co‑CEO Crystal John Adler III reported automatic conversions of Series C preferred stock into common stock of MOVE. On July 7, 2026, 3,345.5239 shares of Series C Non‑Voting Convertible Preferred Stock converted into 3,345,523 shares of common stock, and 708.1544 Series C shares held through the John Adler Crystal III Roth IRA converted into 708,154 common shares, all at a 1‑to‑1,000 conversion ratio. Following these conversions, Adler holds 6,414,723 common shares directly and 711,321 common shares indirectly through the Roth IRA, and no Series C Preferred Stock remains outstanding in these positions.
Corvex, Inc. director Emily Fairbairn reported an automatic conversion of preferred stock into common shares held through affiliated entities. On July 7, 2026, 1,205.2825 shares of Series C Non-Voting Convertible Preferred Stock converted into 1,205,282 common shares at a 1-to-1,000 ratio.
The converted shares, together with existing holdings, are owned indirectly through Moira Partners, a charitable remainder unitrust, and Valley High Limited Partnership, plus 228,577 shares held directly. Fairbairn has voting and investment power over these entities but disclaims beneficial ownership beyond her pecuniary interest.
Corvex, Inc. reports several governance and capital-structure changes tied to its merger with Corvex Legacy Holdings. The board appointed Seth Demsey as co-Chief Executive Officer alongside Jay Crystal, consistent with the merger agreement and his prior role leading Corvex OpCo.
Stockholders approved the 2026 Equity Incentive Plan and a new 2026 Employee Stock Purchase Plan, as well as Nasdaq Listing Rule 5635 proposals permitting issuance of more than 20% of common stock upon conversion of Series C and Series D preferred shares and upon vesting of pre-merger equity awards.
The company increased authorized Series D Preferred Stock to 50,000 shares to support a preferred exchange. After stockholder approval, on July 7, 2026 all Series C Preferred Stock converted into common shares, and Series D Preferred Stock conversions representing 4,752,244 common shares were completed. Following these conversions, Corvex has 27,635,745 common shares outstanding, with remaining Series D Preferred Stock convertible into 28,929,592 additional common shares.
Corvex, Inc. director Emily Fairbairn reported new equity awards and a preferred stock exchange. She received 135,800 time-based restricted stock units in Common Stock that vest in three equal annual installments, bringing her directly held common shares to 228,577.
Separately, an entity associated with her, Moira Partners, LLC, exchanged 858.5403 shares of Series C Preferred Stock for 858.5403 shares of Series D Preferred Stock on a one-for-one basis under an Exchange Agreement. Both series are perpetual and each share converts into 1,000 shares of Common Stock, with Series C scheduled to convert on July 7, 2026 and Series D convertible upon delivery of a conversion notice.
Corvex, Inc. reported that CFO Christopher Moreland received an equity grant of 523,211 shares of Common Stock on July 1, 2026. The Form 4 classifies this as a grant or award acquisition at a stated price of $0.00 per share, reflecting compensation rather than a market purchase.
According to the footnote, these shares are time-based restricted stock units that vest in four equal annual installments from the grant date. After this award, Moreland directly holds 523,211 shares, and the filing shows no open-market buys or sells and no remaining derivative positions.
Corvex, Inc. director Patrick Fleury reported equity awards that increase his stake in the company. He received 100,000 shares of common stock as a grant, structured as time-based restricted stock units that vest in three equal annual installments from the grant date.
He was also granted stock options for 200,000 shares of common stock at an exercise price of $21.06 per share, expiring on July 1, 2036. These options vest in three equal annual installments from the grant date. After these awards, his reported direct holdings are 100,000 shares and options on 200,000 shares.
DONOFRIO NICHOLAS M reported acquisition or exercise transactions in this Form 4 filing.
Corvex, Inc. director Nicholas M. Donofrio received an equity grant of 50,000 shares of Common Stock in the form of restricted stock units. The Form 4 shows this as an award transaction with no cash price per share.
The footnote explains these are time-based restricted stock units that vest in three equal annual installments starting from the grant date. Following this grant, Donofrio holds 50,000 shares directly, indicating this is a new equity-based compensation award rather than an open-market purchase or sale.
Cullinan Brian reported acquisition or exercise transactions in this Form 4 filing.
Corvex, Inc. director Brian Cullinan received a grant of 50,000 shares of Common Stock in the form of time-based restricted stock units. These RSUs vest in three equal annual installments from the grant date, meaning the shares are earned over three years as service continues. Following this award, Cullinan directly holds 111,276 shares of Corvex common stock. This is a compensation-related equity grant rather than an open-market purchase or sale.